Abstract
Background: Cannabis use has increased over the past several years as some countries have legalized its use for the treatment of certain medical conditions and/or for recreational use. Thus, concerns have risen about potential adverse health effects. Increasing number of reports have associated cannabis use with serious cardiovascular (CV) complications. Furthermore, there appears to be a likeness in the harmful health effects, especially on the CV and respiratory systems, of cannabis smoking to those of tobacco smoking.
Objective: To review the CV effects of cannabis use and compare them with those of tobacco use.
Methods: Articles were reviewed that were published in English literature reporting on cannabis and cannabinoid pharmacology and their effects on the CV system and their consequences. Emphasis was also placed on articles reporting on cannabis use in adolescents, exposure to secondhand smoke, its effect on exercise and finally its inter-relationship and similarities with tobacco use.
Results: With growing cannabis use, an increasing number of reports have emerged associating marijuana use with serious and life-threatening CV complications, including acute coronary syndromes, potentially lethal cardiac arrhythmias and ischemic strokes. There are certain similarities of the deleterious CV and respiratory effects of cannabis smoking with those of tobacco smoking. Despite the difference in the active ingredients (tetrahydrocannabinol vs. nicotine), each substance produces a plethora of chemicals when smoked and these are largely identical; furthermore, due to different modes of smoking, cannabis chemicals are retained in the body for a longer time. Of course, concomitant tobacco and cannabis smoking is a perplexing factor in isolating damages specifically pertaining to cannabis use, while the health risk is additive. Although the mechanisms producing CV harm may be somewhat different between these two substances, the outcome appears similar, or even worse, as the effects may emerge at a younger age.
Conclusion: There is an increasing concern that, apart from the mental health problem with cannabis smoking, societies may be facing another wave of a déjà vu/déjà vécu phenomenon similar to the tobacco smoking story.
Keywords: Acute coronary syndromes, cannabinoids, cannabis, cardiovascular disease, CB1/CB2 receptors, marijuana, tetrahydrocannabinol, cardiac arrhythmias.
Graphical Abstract
[1]
Piano, M.R. Cannabis smoking and cardiovascular health: It’s complicated. Clin. Pharmacol. Ther., 2017, 102(2), 191-193.
[2]
National Academies of Sciences Engineering and Medicine National
Academies Press (US): Washington (DC),, 2017. p.
[http://dx.doi.org/10.17226/24625.]
[http://dx.doi.org/10.17226/24625.]
[4]
Volkow, N.D.; Baler, R.D.; Compton, W.M.; Weiss, S.R. Adverse health effects of marijuana use. N. Engl. J. Med., 2014, 370(23), 2219-2227.
[5]
Thomas, G.; Kloner, R.A.; Rezkalla, S. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: What cardiologists need to know. Am. J. Cardiol., 2014, 113(1), 187-190.
[6]
Rodondi, N.; Pletcher, M.J.; Liu, K.; Hulley, S.B.; Sidney, S. Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study). Am. J. Cardiol., 2006, 98(4), 478-484.
[7]
Jouanjus, E.; Lapeyre-Mestre, M.; Micallef, J. Cannabis use: Signal of increasing risk of serious cardiovascular disorders. J. Am. Heart Assoc., 2014, 3(2)e000638
[8]
Jouanjus, E.; Raymond, V.; Lapeyre-Mestre, M.; Wolff, V. What is the current knowledge about the cardiovascular risk for users of cannabis-based products? A systematic review. Curr. Atheroscler. Rep., 2017, 19(6), 26.
[9]
World Health Organization The health and social effects of nonmedical cannabis use., http://www.who.int/substance_abuse/ publications/msbcannabis.pdf2016.
[10]
Ashton, C.H. Pharmacology and effects of cannabis: A brief review. Br. J. Psychiatry, 2001, 178, 101-106.
[11]
Kunos, G.; Jarai, Z.; Batkai, S.; Goparaju, S.K.; Ishac, E.J.; Liu, J.; Wang, L.; Wagner, J.A. Endocannabinoids as cardiovascular modulators. Chem. Phys. Lipids, 2000, 108(1-2), 159-168.
[12]
Chen, D.J.; Gao, M.; Gao, F.F.; Su, Q.X.; Wu, J. Brain cannabinoid receptor 2: Expression, function and modulation. Acta Pharmacol. Sin., 2017, 38(3), 312-316.
[13]
Jiang, L.S.; Pu, J.; Han, Z.H.; Hu, L.H.; He, B. Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages. Cardiovasc. Res., 2009, 81(4), 805-813.
[14]
Singla, S.; Sachdeva, R.; Mehta, J.L. Cannabinoids and atherosclerotic coronary heart disease. Clin. Cardiol., 2012, 35(6), 329-335.
[15]
Sugamura, K.; Sugiyama, S.; Nozaki, T.; Matsuzawa, Y.; Izumiya, Y.; Miyata, K.; Nakayama, M.; Kaikita, K.; Obata, T.; Takeya, M.; Ogawa, H. Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages. Circulation, 2009, 119(1), 28-36.
[16]
Zhao, Y.; Liu, Y.; Zhang, W.; Xue, J.; Wu, Y.Z.; Xu, W.; Liang, X.; Chen, T.; Kishimoto, C.; Yuan, Z. WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice. Eur. J. Pharmacol., 2010, 649(1-3), 285-292.
[17]
Nissen, S.E.; Nicholls, S.J.; Wolski, K.; Rodes-Cabau, J.; Cannon, C.P.; Deanfield, J.E.; Despres, J.P.; Kastelein, J.J.; Steinhubl, S.R.; Kapadia, S.; Yasin, M.; Ruzyllo, W.; Gaudin, C.; Job, B.; Hu, B.; Bhatt, D.L.; Lincoff, A.M.; Tuzcu, E.M. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: The STRADIVARIUS randomized controlled trial. JAMA, 2008, 299(13), 1547-1560.
[18]
O’Leary, D.H.; Reuwer, A.Q.; Nissen, S.E.; Despres, J.P.; Deanfield, J.E.; Brown, M.W.; Zhou, R.; Zabbatino, S.M.; Job, B.; Kastelein, J.J.; Visseren, F.L. Effect of rimonabant on carotid intima-media thickness (CIMT) progression in patients with abdominal obesity and metabolic syndrome: The AUDITOR trial. Heart, 2011, 97(14), 1143-1150.
[19]
Tai, S.; Fantegrossi, W.E. Pharmacological and toxicological effects of synthetic cannabinoids and their metabolites. Curr. Top. Behav. Neurosci., 2017, 32, 249-262.
[20]
Servoss, S.J.; Januzzi, J.L.; Muller, J.E. Triggers of acute coronary syndromes. Prog. Cardiovasc. Dis., 2002, 44(5), 369-380.
[21]
Lindsay, A.C.; Foale, R.A.; Warren, O.; Henry, J.A. Cannabis as a precipitant of cardiovascular emergencies. Int. J. Cardiol., 2005, 104(2), 230-232.
[22]
Aryana, A.; Williams, M.A. Marijuana as a trigger of cardiovascular events: Speculation or scientific certainty? Int. J. Cardiol., 2007, 118(2), 141-144.
[23]
Jehangir, W.; Stanton, M.; Khan, R.; Sahgal, P.; Yousif, A. Did cannabis precipitate an stemi in a young woman? Cardiol. Res., 2015, 6(3), 283-285.
[24]
Nawrot, T.S.; Perez, L.; Kunzli, N.; Munters, E.; Nemery, B. Public health importance of triggers of myocardial infarction: A comparative risk assessment. Lancet, 2011, 377(9767), 732-740.
[25]
Mittleman, M.A.; Lewis, R.A.; Maclure, M.; Sherwood, J.B.; Muller, J.E. Triggering myocardial infarction by marijuana. Circulation, 2001, 103(23), 2805-2809.
[26]
Draz, E.I.; Oreby, M.M.; Elsheikh, E.A.; Khedr, L.A.; Atlam, S.A. Marijuana use in acute coronary syndromes. Am. J. Drug Alcohol Abuse, 2017, 43(5), 576-582.
[27]
Desai, R.; Patel, U.; Sharma, S.; Amin, P.; Bhuva, R.; Patel, M.S.; Sharma, N.; Shah, M.; Patel, S.; Savani, S.; Batra, N.; Kumar, G. Recreational marijuana use and acute myocardial infarction: Insights from nationwide inpatient sample in the united states. Cureus, 2017, 9(11)e1816
[28]
Tatli, E.; Yilmaztepe, M.; Altun, G.; Altun, A. Cannabis-induced coronary artery thrombosis and acute anterior myocardial infarction in a young man. Int. J. Cardiol., 2007, 120(3), 420-422.
[29]
Hamdan, R. Cannabis related coronary thrombosis confirmed by optical coherence tomography. J. Clin. Case Rep., 2014, 4, 7.
[30]
Dahdouh, Z.; Roule, V.; Lognone, T.; Sabatier, R.; Grollier, G. Cannabis and coronary thrombosis: What is the role of platelets? Platelets, 2012, 23(3), 243-245.
[31]
De Angelis, V.; Koekman, A.C.; Weeterings, C.; Roest, M.; de Groot, P.G.; Herczenik, E.; Maas, C. Endocannabinoids control platelet activation and limit aggregate formation under flow. PLoS One, 2014, 9(9)e108282
[32]
Levy, R.; Schurr, A.; Nathan, I.; Dvilanski, A.; Livne, A. Impairment of ADP-induced platelet aggregation by hashish components. Thromb. Haemost., 1976, 36(3), 634-640.
[33]
Cappelli, F.; Lazzeri, C.; Gensini, G.F.; Valente, S. Cannabis: A trigger for acute myocardial infarction? A case report. J. Cardiovasc. Med. (Hagerstown), 2008, 9(7), 725-728.
[34]
Bailly, C.; Merceron, O.; Hammoudi, N.; Dorent, R.; Michel, P.L. Cannabis induced acute coronary syndrome in a young female. Int. J. Cardiol., 2010, 143(1), e4-e6.
[35]
Kocabay, G.; Yildiz, M.; Duran, N.E.; Ozkan, M. Acute inferior myocardial infarction due to cannabis smoking in a young man. J. Cardiovasc. Med. (Hagerstown), 2009, 10(9), 669-670.
[36]
Deusch, E.; Kress, H.G.; Kraft, B.; Kozek-Langenecker, S.A. The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets. Anesth. Analg., 2004, 99(4), 1127-1130.
[37]
Safaa, A.M.; Markham, R.; Jayasinghe, R. Marijuana-induced recurrent acute coronary syndrome with normal coronary angiograms. Drug Alcohol Rev., 2012, 31(1), 91-94.
[38]
Casier, I.; Vanduynhoven, P.; Haine, S.; Vrints, C.; Jorens, P.G. Is recent cannabis use associated with acute coronary syndromes? An illustrative case series. Acta Cardiol., 2014, 69(2), 131-136.
[39]
Rezkalla, S.H.; Sharma, P.; Kloner, R.A. Coronary no-flow and ventricular tachycardia associated with habitual marijuana use. Ann. Emerg. Med., 2003, 42(3), 365-369.
[40]
Mukamal, K.J.; Maclure, M.; Muller, J.E.; Mittleman, M.A. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am. Heart J., 2008, 155(3), 465-470.
[41]
Frost, L.; Mostofsky, E.; Rosenbloom, J.I.; Mukamal, K.J.; Mittleman, M.A. Marijuana use and long-term mortality among survivors of acute myocardial infarction. Am. Heart J., 2013, 165(2), 170-175.
[42]
DeFilippis, E.M.; Singh, A.; Divakaran, S.; Gupta, A.; Collins, B.L.; Biery, D.; Qamar, A.; Fatima, A.; Ramsis, M.; Pipilas, D.; Rajabi, R.; Eng, M.; Hainer, J.; Klein, J.; Januzzi, J.L.; Nasir, K.; Di Carli, M.F.; Bhatt, D.L.; Blankstein, R. Cocaine and marijuana use among young adults presenting with myocardial infarction: The partners young-mi registry. J. Am. Coll. Cardiol., 2018, 71(22), 2540-2551.
[43]
Reece, A.S.; Norman, A.; Hulse, G.K. Cannabis exposure as an interactive cardiovascular risk factor and accelerant of organismal ageing: A longitudinal study. BMJ Open, 2016, 6(11)e011891
[44]
Steffens, S.; Veillard, N.R.; Arnaud, C.; Pelli, G.; Burger, F.; Staub, C.; Karsak, M.; Zimmer, A.; Frossard, J.L.; Mach, F. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature, 2005, 434(7034), 782-786.
[45]
Jayanthi, S.; Buie, S.; Moore, S.; Herning, R.I.; Better, W.; Wilson, N.M.; Contoreggi, C.; Cadet, J.L. Heavy marijuana users show increased serum apolipoprotein C-III levels: Evidence from proteomic analyses. Mol. Psychiatry, 2010, 15(1), 101-112.
[46]
Franz, C.A.; Frishman, W.H. Marijuana use and cardiovascular disease. Cardiol. Rev., 2016, 24(4), 158-162.
[47]
Ting, J.Y. Reversible cardiomyopathy associated with acute inhaled marijuana use in a young adult. Clin. Toxicol. (Phila.), 2007, 45(4), 432-434.
[48]
Kaushik, M.; Alla, V.M.; Madan, R.; Arouni, A.J.; Mohiuddin, S.M. Recurrent stress cardiomyopathy with variable regional involvement: Insights into etiopathogenetic mechanisms. Circulation, 2011, 124(22), e556-e557.
[49]
Nogi, M.; Fergusson, D.; Chiaco, J.M. Mid-ventricular variant takotsubo cardiomyopathy associated with Cannabinoid Hyperemesis Syndrome: a case report. Hawaii J. Med. Public Health, 2014, 73(4), 115-118.
[50]
Del Buono, M.G.; O’Quinn, M.P.; Garcia, P.; Gerszten, E.; Roberts, C.; Moeller, F.G.; Abbate, A. Cardiac arrest due to ventricular fibrillation in a 23-year-old woman with broken heart syndrome. Cardiovasc. Pathol., 2017, 30, 78-81.
[51]
Korantzopoulos, P.; Liu, T.; Papaioannides, D.; Li, G.; Goudevenos, J.A. Atrial fibrillation and marijuana smoking. Int. J. Clin. Pract., 2008, 62(2), 308-313.
[52]
Krishnamoorthy, S.; Lip, G.Y.; Lane, D.A. Alcohol and illicit drug use as precipitants of atrial fibrillation in young adults: A case series and literature review. Am. J. Med., 2009, 122(9), 851-856.e853.
[53]
Kosior, D.A.; Filipiak, K.J.; Stolarz, P.; Opolski, G. Paroxysmal atrial fibrillation following marijuana intoxication: A two-case report of possible association. Int. J. Cardiol., 2001, 78(2), 183-184.
[54]
Singh, D.; Huntwork, M.; Shetty, V.; Sequeira, G.; Akingbola, O. Prolonged atrial fibrillation precipitated by new-onset seizures and marijuana abuse. Pediatrics, 2014, 133(2), e443-e446.
[55]
Korantzopoulos, P. Marijuana smoking is associated with atrial fibrillation. Am. J. Cardiol., 2014, 113(6), 1085-1086.
[56]
Fisher, B.A.; Ghuran, A.; Vadamalai, V.; Antonios, T.F. Cardiovascular complications induced by cannabis smoking: A case report and review of the literature. Emerg. Med. J., 2005, 22(9), 679-680.
[57]
Bachs, L.; Morland, H. Acute cardiovascular fatalities following cannabis use. Forensic Sci. Int., 2001, 124(2-3), 200-203.
[58]
Montisci, M.; Thiene, G.; Ferrara, S.D.; Basso, C. Cannabis and cocaine: A lethal cocktail triggering coronary sudden death. Cardiovasc. Pathol., 2008, 17(5), 344-346.
[59]
Hartung, B.; Kauferstein, S.; Ritz-Timme, S.; Daldrup, T. Sudden unexpected death under acute influence of cannabis. Forensic Sci. Int., 2014, 237, e11-e13.
[60]
Orsini, J.; Blaak, C.; Rajayer, S.; Gurung, V.; Tam, E.; Morante, J.; Shamian, B.; Malik, R. Prolonged cardiac arrest complicating a massive ST-segment elevation myocardial infarction associated with marijuana consumption. J. Community Hosp. Intern. Med. Perspect., 2016, 6(4), 31695.
[61]
Davis, C.; Boddington, D. Teenage cardiac arrest following abuse of synthetic cannabis. Heart Lung Circ., 2015, 24(10), e162-e163.
[62]
Pratap, B.; Korniyenko, A. Toxic effects of marijuana on the cardiovascular system. Cardiovasc. Toxicol., 2012, 12(2), 143-148.
[63]
Alonso, J.V.; Teo, B.H.; Pozo, F.J.; Aguayo, M.A.; Sanchez, A. Brugada electrocardiogram pattern induced by cannabis; Is cannabis
safe? Am. J. Emerg. Med, 2016, 34(8), 1738.e1731-1734.
[64]
Diffley, M.; Armenian, P.; Gerona, R.; Reinhartz, O.; Avasarala, K. Catecholaminergic polymorphic ventricular tachycardia found in an adolescent after a methylenedioxymethamphetamine and marijuana-induced cardiac arrest. Crit. Care Med., 2012, 40(7), 2223-2226.
[65]
Menahem, S. Cardiac asystole following cannabis (marijuana) usage-additional mechanism for sudden death? Forensic Sci. Int., 2013, 233(1-3), e3-e5.
[66]
Sattout, A.H.; Nicol, M.F. Cardiac arrest following cannabis use: A case report. Cases J., 2009, 2, 208.
[67]
Scragg, R.K.; Mitchell, E.A.; Ford, R.P.; Thompson, J.M.; Taylor, B.J.; Stewart, A.W. Maternal cannabis use in the sudden death syndrome. Acta Paediatr., 2001, 90(1), 57-60.
[68]
Klonoff-Cohen, H.; Lam-Kruglick, P. Maternal and paternal recreational drug use and sudden infant death syndrome. Arch. Pediatr. Adolesc. Med., 2001, 155(7), 765-770.
[69]
Beaconsfield, P.; Ginsburg, J.; Rainsbury, R. Marihuana smoking: Cardiovascular effects in man and possible mechanisms. N. Engl. J. Med., 1972, 287(5), 209-212.
[70]
Jones, R.T. Cardiovascular system effects of marijuana. J. Clin. Pharmacol., 2002, 42(11)(Suppl.), 58s-63s.
[71]
Benowitz, N.L.; Jones, R.T. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin. Pharmacol. Ther., 1975, 18(3), 287-297.
[72]
Yankey, B.A.; Rothenberg, R.; Strasser, S.; Ramsey-White, K.; Okosun, I.S. Effect of marijuana use on cardiovascular and cerebrovascular mortality: A study using the national health and nutrition examination survey linked mortality file. Eur. J. Prev. Cardiol., 2018, 24(17), 1833-1840.
[73]
Alshaarawy, O.; Elbaz, H.A. Cannabis use and blood pressure levels: United states national health and nutrition examination survey, 2005-2012. J. Hypertens., 2016, 34(8), 1507-1512.
[74]
Nowlan, R.; Cohen, S. Tolerance to marijuana: Heart rate and subjective “high”. Clin. Pharmacol. Ther., 1977, 22(5 Pt 1), 550-556.
[75]
Vandrey, R.; Umbricht, A.; Strain, E.C. Increased blood pressure after abrupt cessation of daily cannabis use. J. Addict. Med., 2011, 5(1), 16-20.
[76]
Barber, P.A.; Pridmore, H.M.; Krishnamurthy, V.; Roberts, S.; Spriggs, D.A.; Carter, K.N.; Anderson, N.E. Cannabis, ischemic stroke, and transient ischemic attack: A case-control study. Stroke, 2013, 44(8), 2327-2329.
[77]
Mateo, I.; Pinedo, A.; Gomez-Beldarrain, M.; Basterretxea, J.M.; Garcia-Monco, J.C. Recurrent stroke associated with cannabis use. J. Neurol. Neurosurg. Psychiatry, 2005, 76(3), 435-437.
[78]
Singh, N.N.; Pan, Y.; Muengtaweeponsa, S.; Geller, T.J.; Cruz-Flores, S. Cannabis-related stroke: Case series and review of literature. J. Stroke Cerebrovasc. Dis., 2012, 21(7), 555-560.
[80]
Hackam, D.G. Cannabis and stroke: Systematic appraisal of case reports. Stroke, 2015, 46(3), 852-856.
[81]
Wolff, V.; Lauer, V.; Rouyer, O.; Sellal, F.; Meyer, N.; Raul, J.S.; Sabourdy, C.; Boujan, F.; Jahn, C.; Beaujeux, R.; Marescaux, C. Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: A prospective study in 48 consecutive young patients. Stroke, 2011, 42(6), 1778-1780.
[82]
Wolff, V.; Armspach, J.P.; Beaujeux, R.; Manisor, M.; Rouyer, O.; Lauer, V.; Meyer, N.; Marescaux, C.; Geny, B. High frequency of intracranial arterial stenosis and cannabis use in ischaemic stroke in the young. Cerebrovasc. Dis., 2014, 37(6), 438-443.
[83]
Renard, D.; Taieb, G.; Gras-Combe, G.; Labauge, P. Cannabis-related myocardial infarction and cardioembolic stroke. J. Stroke Cerebrovasc. Dis., 2012, 21(1), 82-83.
[84]
Wolff, V.; Armspach, J.P.; Lauer, V.; Rouyer, O.; Bataillard, M.; Marescaux, C.; Geny, B. Cannabis-related stroke: Myth or reality? Stroke, 2013, 44(2), 558-563.
[85]
Wolff, V.; Jouanjus, E. Strokes are possible complications of cannabinoids use. Epilepsy Behav, 2017, 70(Pt B). , 355-363.
[86]
Disdier, P.; Granel, B.; Serratrice, J.; Constans, J.; Michon-Pasturel, U.; Hachulla, E.; Conri, C.; Devulder, B.; Swiader, L.; Piquet, P.; Branchereau, A.; Jouglard, J.; Moulin, G.; Weiller, P.J. Cannabis arteritis revisited-ten new case reports. Angiology, 2001, 52(1), 1-5.
[87]
Peyrot, I.; Garsaud, A.M.; Saint-Cyr, I.; Quitman, O.; Sanchez, B.; Quist, D. Cannabis arteritis: A new case report and a review of literature. J. Eur. Acad. Dermatol. Venereol., 2007, 21(3), 388-391.
[88]
Desbois, A.C.; Cacoub, P. Cannabis-associated arterial disease. Ann. Vasc. Surg., 2013, 27(7), 996-1005.
[89]
Rezkalla, S.; Stankowski, R.; Kloner, R.A. Cardiovascular effects of marijuana. J. Cardiovasc. Pharmacol. Ther., 2016, 21(5), 452-455.
[91]
Santos, R.P.; Resende, C.I.; Vieira, A.P.; Brito, C. Cannabis arteritis: Ever more important to consider. BMJ Case Rep, 2017, 2017
[92]
Henry, J.A.; Oldfield, W.L.; Kon, O.M. Comparing cannabis with tobacco. BMJ, 2003, 326(7396), 942-943.
[93]
Meier, M.H.; Caspi, A.; Ambler, A.; Harrington, H.; Houts, R.; Keefe, R.S.; McDonald, K.; Ward, A.; Poulton, R.; Moffitt, T.E. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc. Natl. Acad. Sci. USA, 2012, 109(40), E2657-E2664.
[94]
Blakemore, S.J. Teenage kicks: Cannabis and the adolescent brain. Lancet, 2013, 381(9870), 888-889.
[95]
Stanley, C.; O’Sullivan, S.E. Vascular targets for cannabinoids: Animal and human studies. Br. J. Pharmacol., 2014, 171(6), 1361-1378.
[96]
Fairman, B.J.; Furr-Holden, C.D.; Johnson, R.M. When marijuana is used before cigarettes or alcohol: Demographic predictors and associations with heavy use, cannabis use disorder, and other drug-related outcomes. Prev. Sci., 2019, 20(2), 225-233.
[97]
Mokrysz, C.; Freeman, T.P.; Korkki, S.; Griffiths, K.; Curran, H.V. Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males. Transl. Psychiatry, 2016, 6(11)e961
[98]
Moir, D.; Rickert, W.S.; Levasseur, G.; Larose, Y.; Maertens, R.; White, P.; Desjardins, S. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem. Res. Toxicol., 2008, 21(2), 494-502.
[99]
Wang, X.; Derakhshandeh, R.; Liu, J.; Narayan, S.; Nabavizadeh, P.; Le, S.; Danforth, O.M.; Pinnamaneni, K.; Rodriguez, H.J.; Luu, E.; Sievers, R.E.; Schick, S.F.; Glantz, S.A.; Springer, M.L. One minute of marijuana secondhand smoke exposure substantially impairs vascular endothelial function. J. Am. Heart Assoc., 2016, 5(8)e003858
[100]
Goodwin, R.D.; Cheslack-Postava, K.; Santoscoy, S.; Bakoyiannis, N.; Hasin, D.S.; Collins, B.N.; Lepore, S.J.; Wall, M.M. Trends in cannabis and cigarette use among parents with children at home: 2002 to 2015. Pediatrics, 2018, 14e20173506
[101]
Kennedy, M.C. Cannabis: Exercise performance and sport. A systematic review. J. Sci. Med. Sport, 2017, 20(9), 825-829.
[102]
Aronow, W.S.; Cassidy, J. Effect of marihuana and placebo-marihuana smoking on angina pectoris. N. Engl. J. Med., 1974, 291(2), 65-67.
[103]
Martinasek, M.P.; McGrogan, J.B.; Maysonet, A. A systematic review of the respiratory effects of inhalational marijuana. Respir. Care, 2016, 61(11), 1543-1551.
[104]
Biehl, J.R.; Burnham, E.L. Cannabis smoking in 2015: A concern for lung health? Chest, 2015, 148(3), 596-606.
[105]
Macleod, J.; Robertson, R.; Copeland, L.; McKenzie, J.; Elton, R.; Reid, P. Cannabis, tobacco smoking, and lung function: A cross-sectional observational study in a general practice population. Br. J. Gen. Pract., 2015, 65(631), e89-e95.
[106]
Imtiaz, S.; Shield, K.D.; Roerecke, M.; Cheng, J.; Popova, S.; Kurdyak, P.; Fischer, B.; Rehm, J. The burden of disease attributable to cannabis use in Canada in 2012. Addiction, 2016, 111(4), 653-662.
[107]
Fischer, B.; Imtiaz, S.; Rudzinski, K.; Rehm, J. Crude estimates of cannabis-attributable mortality and morbidity in Canada-implications for public health focused intervention priorities. J. Public Health (Oxf.), 2016, 38(1), 183-188.
[108]
Kilmer, B. Recreational cannabis - minimizing the health risks from legalization. N. Engl. J. Med., 2017, 376(8), 705-707.
Related Books
Science of Spices and Culinary Herbs - Latest Laboratory, Pre-clinical, and Clinical Studies
Frontiers in Natural Product Chemistry
Therapeutic Use of Plant Secondary Metabolites
Therapeutic Implications of Natural Bioactive Compounds
Frontiers in Bioactive Compounds
Frontiers in Natural Product Chemistry
Frontiers in Natural Product Chemistry
Science of Spices and Culinary Herbs - Latest Laboratory, Pre-clinical, and Clinical Studies
Frontiers in Natural Product Chemistry
Frontiers in Natural Product Chemistry
Article Metrics
49
5